• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病脑灰质与白质中的播散性 Tau。

Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain.

机构信息

Department of Neurochemistry, Inge Grundke-Iqbal Research Floor, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA.

Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education of China, Nantong University, Nantong, Jiangsu, China.

出版信息

J Alzheimers Dis. 2021;79(4):1647-1659. doi: 10.3233/JAD-201290.

DOI:10.3233/JAD-201290
PMID:33459649
Abstract

BACKGROUND

Neurofibrillary pathology of abnormally hyperphosphorylated tau spreads along neuroanatomical connections, underlying the progression of Alzheimer's disease (AD). The propagation of tau pathology to axonally connected brain regions inevitably involves trafficking of seeding-competent tau within the axonal compartment of the neuron.

OBJECTIVE

To determine the seeding activity of tau in cerebral gray and white matters of AD.

METHODS

Levels of total tau, hyperphosphorylation of tau, and SDS- and β-mercaptoethanol-resistant high molecular weight tau (HMW-tau) in crude extracts from gray and white matters of AD frontal lobes were analyzed by immuno-blots. Tau seeding activity was quantitatively assessed by measuring RIPA buffer-insoluble tau in HEK-293FT/tau151-391 cells treated with brain extracts.

RESULTS

We found a comparable level of soluble tau in gray matter versus white matter of control brains, but a higher level of soluble tau in gray matter than white matter of AD brains. In AD brains, tau is hyperphosphorylated in both gray and white matters, with a higher level in the former. The extracts of both gray and white matters of AD brains seeded tau aggregation in HEK-293FT/tau151-391 cells but the white matter showed less potency. Seeding activity of tau in brain extracts was positively correlated with the levels of tau hyperphosphorylation and HMW-tau. RIPA-insoluble tau, but not RIPA-soluble tau, was hyperphosphorylated tau at multiple sites.

CONCLUSION

Both gray and white matters of AD brain contain seeding-competent tau that can template aggregation of hyperphosphorylated tau, but the seeding potency is markedly higher in gray matter than in white matter.

摘要

背景

异常过度磷酸化的 tau 的神经纤维缠结沿着神经解剖连接扩散,这是阿尔茨海默病(AD)进展的基础。tau 病理学向轴突连接的脑区传播不可避免地涉及到在神经元的轴突隔室内运输有种子能力的 tau。

目的

确定 AD 大脑灰质和白质中 tau 的种子活性。

方法

通过免疫印迹分析 AD 额叶大脑灰质和白质粗提物中总 tau、tau 过度磷酸化以及 SDS 和 β-巯基乙醇抗性高分子量 tau(HMW-tau)的水平。通过测量用脑提取物处理的 HEK-293FT/tau151-391 细胞中 RIPA 缓冲液不溶性 tau,定量评估 tau 种子活性。

结果

我们发现对照脑灰质与白质中的可溶性 tau 水平相当,但 AD 脑灰质中的可溶性 tau 水平高于白质。在 AD 脑中,tau 在灰质和白质中均过度磷酸化,前者水平更高。AD 脑的灰质和白质提取物均可在 HEK-293FT/tau151-391 细胞中引发 tau 聚集,但白质的效力较低。脑提取物中 tau 的种子活性与 tau 过度磷酸化和 HMW-tau 的水平呈正相关。RIPA 不溶性 tau 而不是 RIPA 可溶性 tau 在多个位点发生过度磷酸化。

结论

AD 脑的灰质和白质均含有有种子能力的 tau,可模板聚集过度磷酸化的 tau,但灰质中的种子活性明显高于白质。

相似文献

1
Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain.阿尔茨海默病脑灰质与白质中的播散性 Tau。
J Alzheimers Dis. 2021;79(4):1647-1659. doi: 10.3233/JAD-201290.
2
Tau seeding activity in various regions of down syndrome brain assessed by two novel assays.通过两种新的检测方法评估唐氏综合征大脑各区域 Tau 的种子活性。
Acta Neuropathol Commun. 2022 Sep 5;10(1):132. doi: 10.1186/s40478-022-01436-2.
3
Two simple assays for assessing the seeding activity of proteopathic tau.两种评估蛋白病性tau种子活性的简单检测方法。
Front Aging Neurosci. 2023 Apr 6;15:1073774. doi: 10.3389/fnagi.2023.1073774. eCollection 2023.
4
Alzheimer's disease brain contains tau fractions with differential prion-like activities.阿尔茨海默病大脑中含有具有不同类朊病毒样活性的 tau 片段。
Acta Neuropathol Commun. 2021 Feb 17;9(1):28. doi: 10.1186/s40478-021-01127-4.
5
Pathological Changes of Tau Related to Alzheimer's Disease.tau 相关的阿尔茨海默病的病理变化。
ACS Chem Neurosci. 2019 Feb 20;10(2):931-944. doi: 10.1021/acschemneuro.8b00457. Epub 2018 Oct 23.
6
Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).人类大脑中神经原纤维病变丰富的区域,其具有结合能力的tau蛋白水平会选择性降低,且异常tau异构体(A68蛋白)会积累。
Lab Invest. 1992 Feb;66(2):212-22.
7
Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.阿尔茨海默病和 3xTg-AD 小鼠脑组织中 Tau 的病理改变。
Mol Neurobiol. 2019 Sep;56(9):6168-6183. doi: 10.1007/s12035-019-1507-4. Epub 2019 Feb 8.
8
Topographic regulation of kinase activity in Alzheimer's disease brains.阿尔茨海默病大脑中激酶活性的拓扑调节
J Alzheimers Dis. 2002 Aug;4(4):269-81. doi: 10.3233/jad-2002-4402.
9
Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue.鉴定甲醛固定组织中的tau 朊病毒种子活性和株系。
Acta Neuropathol Commun. 2017 Jun 7;5(1):41. doi: 10.1186/s40478-017-0442-8.
10
GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.在向中枢神经系统注射阿尔茨海默病脑源性病理性tau蛋白或合成突变型人tau蛋白原纤维后,绿色荧光蛋白标记的突变型人tau转基因小鼠出现tau蛋白病。
J Neurosci. 2017 Nov 22;37(47):11485-11494. doi: 10.1523/JNEUROSCI.2393-17.2017. Epub 2017 Oct 6.

引用本文的文献

1
Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models.塑造成功治疗阿尔茨海默病的疾病修饰药物的临床前开发的未来:tau 传播模型的系统评价。
Acta Neuropathol Commun. 2024 Apr 4;12(1):52. doi: 10.1186/s40478-024-01748-5.
2
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change.在 AD 神经病理学改变程度较低的情况下,区域性 AT-8 反应性 tau 种与细胞内 Aβ 水平相关。
Acta Neuropathol. 2024 Feb 14;147(1):40. doi: 10.1007/s00401-024-02691-4.
3
Tau seeding activity in various regions of down syndrome brain assessed by two novel assays.
通过两种新的检测方法评估唐氏综合征大脑各区域 Tau 的种子活性。
Acta Neuropathol Commun. 2022 Sep 5;10(1):132. doi: 10.1186/s40478-022-01436-2.